Tirzepatide is the first medication in a new drug class sometimes known as a twincretin, because it targets two hormone receptors that regulate insulin and metabolism
In a 26-week phase 2 study involving patients with obesity and T2DM, treatment with tirzepatide dose-dependently decreased the circulating levels of specific biomarkers of inflammation and endothelial dysfunction previously associated with cardiovascular events, suggesting a net improvement in the cardiovascular risk profile of these patients.37 In this post hoc analysis, inflammation, endothelial dysfunction, and cellular stress biomarkers were measured at baseline and 4, 12, and 26 weeks to evaluate the additional effects of tirzepatide on cardiovascular risk factors.37 After 26 weeks, tirzepatide treatment at doses of 10 and 15 mg decreased the levels of YKL-40 (also known as chitinase-3 like-protein-1), intercellular adhesion molecule 1 (ICAM-1), leptin, and growth differentiation factor 15 compared with baseline
Avoid high-fat foods, fried items, and rich sauces during the first 48 weeks, as fat delays stomach emptying further and compounds GLP-1's natural effect
Better-tolerated options for some patients include moong dal khichdi, dalia, idli, poha, curd rice, soups with paneer or sprouts, and soft chapati with dal and sabzi
Obtn orientacin gratis y personalizada sobre planes de Medicare para ayudarte a explorar tus opciones y elegir el plan correcto Podramos estar hablando de millones de personas, dice Juliette Cubanski, vicepresidenta y directora del Programa de Poltica de Medicare en KFF, una organizacin sin fines de lucro y sin afiliacin poltica